Skip to content

Mindfulness-based cognitive therapy for health-related and work-related quality of life in working women with premenstrual syndrome: A cluster randomized controlled trial

Elahe Cholbeigi, Nasim Bahrami, Mohammad Ebrahim Sarichloo, Mark Damian Griffiths, Zainab Alimoradi

Journal of Workplace Behavioral Health October 12, 2026 DOI: 10.1080/15555240.2026.2745955 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Cluster randomized controlled trial Peer reviewed
Sample size 110
Population Working women with premenstrual syndrome (PMS) from 20 schools
Intervention Mindfulness-based cognitive therapy (MBCT)
Duration Eight weekly 45–60-minute group sessions
Measures SF-12, WRQoL, IPMSDLS, FFMQ-15
Topics Meditation
Key findings The prespecified primary analysis found no significant intervention effects on health-related quality of life, work-related quality of life, PMS impact on daily life, or mindfulness (all p > 0.05). Secondary exploratory analyses not accounting for school-level clustering showed greater improvements in the MBCT group with medium effect sizes (partial η2 = 0.108–0.149; all p < 0.001), but the authors state these findings were not confirmed in the primary analysis and do not provide evidence of MBCT effectiveness.

Abstract

This cluster randomized controlled trial examined whether mindfulness-based cognitive therapy (MBCT) improves health-related quality of life (HRQoL), work-related quality of life (WRQoL), and reduces the impact of premenstrual syndrome (PMS) on daily life among working women with PMS. From August 2023 to May 2024, working women from 20 schools were randomized into intervention or control groups, yielding 110 working women with PMS (55 per group). The intervention comprised eight weekly 45–60-minute group MBCT sessions. Outcomes included HRQoL (SF-12), WRQoL, the impact of PMS on daily life (IPMSDLS), and mindfulness (FFMQ-15). The prespecified primary analysis (linear mixed-effects models with school as a random intercept) found no significant intervention effects on any outcome (all p > 0.05). In secondary, exploratory repeated-measures ANCOVA analyses not accounting for school-level clustering, the MBCT group showed significantly greater improvements across all outcomes, with medium effect sizes (partial η2 = 0.108–0.149; all p < 0.001); these exploratory findings were not confirmed in the primary analysis and should be interpreted with caution. Because the cluster-adjusted primary analysis did not confirm a significant intervention effect, the findings do not provide evidence of MBCT effectiveness, although the consistent direction of exploratory findings suggests MBCT may warrant further evaluation in adequately powered cluster-randomized trials.RCT registration The study protocol was prospectively registered in the Iranian Registry of Clinical Trials under decree code IRCT20221213056810N1; 2023-05-05.

Comparable studies

Other randomized controlled trials on meditation, most cited first.

Study Year Design Participants
Alterations in Brain and Immune Function Produced by Mindfulness Meditation Healthy employees in a work environment 2003 Randomized controlled trial n = 41
Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. Recovered recurrently depressed patients 2000 Randomized controlled trial n = 145
Open hearts build lives: Positive emotions, induced through loving-kindness meditation, build consequential personal resources. Working adults 2008 Randomized controlled trial n = 139
Short-term meditation training improves attention and self-regulation Undergraduate Chinese students 2007 Randomized controlled trial n = 40
Mindfulness-Based Cognitive Therapy for Depression: Replication and Exploration of Differential Relapse Prevention Effects. Recovered recurrently depressed patients 2004 Randomized controlled trial n = 73

Citations in the library

Explore topics